US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

6  7  8  9    11    13  14  15  
Osteopenia - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Osteopenia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Osteonecrosis - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Osteonecrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Salivary Gland Cancer - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... information on the therapeutic development for Salivary Gland Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Muscle Spasticity - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Muscle Spasticity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Inclusion Body Myositis (IBM) - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Inclusion Body Myositis (IBM), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Paralysis - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Paralysis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Sinusitis - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Sinusitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Pemphigus - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Pemphigus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acid Sphingomyelinase Deficiency (Niemann-Pick Disease), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...  |  read more...
USD 2,000
Dysmenorrhea - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Dysmenorrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Keratitis - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Keratitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Trauma - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Trauma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Nephropathy - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Nephropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Thromboembolism - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Thromboembolism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... (Urothelial Cell Cancer)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Transitional Cell Cancer (Urothelial Cell Cancer), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of ...  |  read more...
USD 2,000
Muscular Dystrophy - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Muscular Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Pollen Allergy - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Pollen Allergy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Ischemia - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Ischemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Pneumocystis Infection - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Pneumocystis Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Cryptosporidiosis - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Cryptosporidiosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Invaginata, Bamboo Hair)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of ...  |  read more...
USD 2,000
Hypoxia - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Hypoxia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Corneal Ulcers - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Corneal Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Leukodystrophies - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... Leukodystrophies, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Nerve Injury - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Nerve Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
6  7  8  9    11    13  14  15